Daniel Buchman

@danielbuchman.bsky.social

Senior Scientist and Director of the Everyday Ethics Lab at the Centre for Addiction and Mental Health. Associate Professor at the Dalla Lana School of Public Health at the University of Toronto. Views are my own. 🕊️ www.everydayethicslab.ca

A few words on what motivated this paper. Our concern is that we may wake up one day and realize how much influence commercial actors using AI tools can have on health. This risk is greater because AI companies now have a substantial technological advantage over regulators -->

Itai Bavli@itaibavli.bsky.social · 4w ago

How is AI changing the ways commercial actors influence health? Check out our new article published in BMJ: "Artificial intelligence as a new commercial determinant of health." We introduce the AI commercial determinants of health (AI-CDoH) framework 🧵 @bmj.com 1/9

Researchers can use AI-CDoH to examine actors, data, how AI shapes knowledge or behaviour, who is targeted, and health impacts. It can help identify where AI enabled commercial influence occurs, how it operates, and what forms of oversight or intervention may be needed. 8/9

AI platforms as health influencing infrastructure: Chatbots, search engines, social media, and recommendation systems increasingly mediate health advice, self-diagnosis, and purchasing. Their design, data practices, and commercial incentives shape what information and products people see. 7/9

Bild

AI shaping of the public narrative: AI enables highly personalized messaging across chatbots, search, and social media. It can amplify doubt, make commercial claims seem widely accepted, and influence how people understand health risks, products, and responsibility. 6/9

AI regulatory and policy capture: AI can identify regulatory vulnerabilities, tailor arguments to decision makers, and generate submissions at scale. When regulators and public institutions adopt commercial AI systems, biased data or algorithms may also affect regulatory and policy decisions. 5/9

AI knowledge capture: AI can change how scientific evidence is generated, synthesized, framed, and shared. Companies can use it to target clinicians or researchers, amplify favourable findings, and obscure evidence that challenges commercial goals. 4/9

Through this framework (AI-CDoH), we examine: 👉 AI knowledge capture 👉 AI regulatory and policy capture 👉 AI shaping of the public narrative 👉 AI platforms as health influencing infrastructure 3/9

Bild

An AI commercial determinants of health framework can help identify how AI is transforming existing mechanisms of commercial influence and enabling new tactics through which commercial actors may influence health. 2/9

How is AI changing the ways commercial actors influence health? Check out our new article published in BMJ: "Artificial intelligence as a new commercial determinant of health." We introduce the AI commercial determinants of health (AI-CDoH) framework 🧵 @bmj.com 1/9

Bild

I worry that this same is true for journals requiring “disclosure” of gen AI use. Journals can appear to be doing SOMEthing by requiring disclosure of gen AI, but it doesn’t actually improve the quality of manuscripts in the journal.

Daniel Buchman@danielbuchman.bsky.social · last mo.

Agreed, but decades of COI research show disclosure alone is insufficient. It doesn't change the underlying relationship, and can backfire. Audiences may trust a transparent speaker more and scrutinize their data/arguments less. #bioethics #COI www.science.org/content/arti...

Agreed, but decades of COI research show disclosure alone is insufficient. It doesn't change the underlying relationship, and can backfire. Audiences may trust a transparent speaker more and scrutinize their data/arguments less. #bioethics #COI www.science.org/content/arti...

Philosophers call for their journals to require conflict of interest disclosures

A new petition urges greater transparency amid growing ties to AI and other companies

science.org

Another no-hitter heartbreak for this organization, which has had so many over the years. Dave Stieb still stands alone, while Dylan Cease joins the crowded, growing group of #BlueJays pitchers to lose theirs in the ninth. A brilliant, but bittersweet day on the mound.

After the 6th, Dylan Cease told John Schneider he could throw 120 pitches. After the 7th? He said he had 130 in him. Schneider wanted to give it to him: “I’m a fan of baseball … If I can let a player have that opportunity, I’m going to do it every single time.” #BlueJays

I'm so honoured to receive this award. I just try to show up, listen, and support learners who are far more talented than me! Each one has taught me something and challenged my thinking. They remind me why the work we do in bioethics matters. Thank you 🙏 and congrats to all the award recipients!

Dalla Lana School of Public Health@uoftdlsph.bsky.social · 2mo ago

Congratulations to the recipients of the DLSPH’s 2026 Public Health Sciences (PHS) Faculty Awards: Dr. Laura Rosella, Dr. Brice Kuimi, Tony Panzarella, Dr. Dionne Gesink, Dr. Daniel Buchman, Dr. Susan Bondy and Dr. Ibukun Abejirinde (not pictured). 👏

I sat down w/ Dr Dan Cox to chat about the limits of medicine, goals of care, reducing suffering, quality of life, & palliative psychiatry. 🍎https://podcasts.apple.com/us/podcast/what-is-palliative-psychiatry-with-dr-daniel-buchman/id1734318570?i=1000771879361 🛜 open.spotify.com/episode/7Aao...

What is Palliative Psychiatry with Dr. Daniel Buchman | Psychotherapy and Applied Psychology

Dan is joined by Dr. Daniel Buchman, a bioethicist and scientist at the Centre for Addiction and Mental Health and an associate professor in the Dalla Lan…

psychotherapyandappliedpsychology.com

Dr. Buchman's work on this is so important b/c it is widely believed that medicalizing or biologizing chronic disease is a viable pathway to reducing stigma. His work builds the evidence base we need to answer the question: are such approaches important stigma-reducing strategies? #Bioethics

Daniel Buchman@danielbuchman.bsky.social · 4mo ago

🗣️ New paper from the CAMH Everyday Ethics Lab! 🧠 Do disease-based explanations of chronic pain reduce stigma? This is the question we set out to answer in our new paper in the @thejournalofpain.bsky.social #bioethics #neuroethics #stigma 1/9